Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.

@article{Burgos2009TargetedSA,
  title={Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.},
  author={Jos{\'e} Luis Medina Burgos and James G. Kahn and Steffanie Anne Strathdee and Atanacio Valencia-Mendoza and Sergio Bautista-Arredondo and Rafael Laniado-Labor{\'i}n and Rutila Casta{\~n}eda and R Deiss and Richard S. Garfein},
  journal={The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease},
  year={2009},
  volume={13 8},
  pages={962-8}
}
OBJECTIVE To assess the cost-effectiveness of screening for latent tuberculosis infection (LTBI) using a commercially available detection test and treating individuals at high risk for human immunodeficiency virus (HIV) infection in a middle-income country. DESIGN We developed a Markov model to evaluate the cost per LTBI case detected, TB case averted and quality-adjusted life year (QALY) gained for a cohort of 1000 individuals at high risk for HIV infection over 20 years. Baseline model… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…